History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Cycle for Survival Fred's Team Rock & Run on the River Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment
Search About Herbs:

Willow Bark

How It Works

Bottom Line: Willow bark may help relieve muscle and joint pain, but it is not an effective weight loss supplement.

Because aspirin is naturally derived from the bark of the willow tree, willow bark is commonly used to treat pain and reduce fevers. In the body, active molecules in willow bark are converted to salicylic acid, the active component of aspirin. Because of the time it takes for this conversion to take place, scientists have found that the effects of willow bark take a longer time to appear, but last longer than aspirin. Salicylic acid halts an important step in the inflammatory process, which is why it can reduce swelling. It is not yet known whether willow bark has the same anticoagulant effects as aspirin in humans.

Purported Uses

  • To reduce fever
    Willow bark is thought to act in the same way as aspirin, but no there is no proof from clinical trials that this herb can reduce fever.
  • To treat pain, including muscle pain and headaches
    Two clinical trials have shown that willow bark extract is effective in treating low back pain, and one clinical trial suggested that it can reduce the pain of osteoathritis. No other clinical trials have evaluated this use.
  • To reduce inflammation
    Willow bark is converted to salicylic acid in the body; salicylic acid is known to halt the inflammatory process, but there is no proof from clinical trials that willow bark can reduce inflammation in humans.
  • To treat flu
    No scientific evidence supports this use.
  • For weight loss
    No scientific evidence supports this use.

  • Research Evidence

    Back pain
    A large clinical trial studied the effect of willow bark extract on low back pain. For four weeks, 210 patients were randomly given willow bark extract of two different strengths or a placebo pill. They were allowed to use tramadol as a "rescue" medication if their pain was bad enough. At the end of the study, more patients taking the strongest willow bark extract (240 mg of salicin) reported pain relief (39%) than patients taking the placebo (7%). However, this indicates that willow bark helped less than half of the patients taking it. In addition, more patients in the placebo group needed to take tramadol for pain. This clinical trial gives some support to the use of willow bark for low back pain.

    Pain of osteoarthritis
    The effect of willow bark extract on the pain of osteoarthritis was assessed in a clinical trial with 78 patients. For two weeks, patients were randomly assigned to receive willow bark containing 240 mg of salicin or a placebo pill. Patients taking willow bark reported a greater decrease in joint pain than those taking placebo, but there was no real difference in their stiffness or ability to get around. These results indicate that willow bark is effective in reducing pain associated with osteoarthritis of the knee or hip.

    Warnings

  • This product is regulated by the FDA as a dietary supplement. Unlike approved drugs, supplements are not required to be manufactured under specific standardized conditions. This product may not contain the labeled amount or may be contaminated. In addition, it may not have been tested for safety or effectiveness.
  • Because it can thin the blood, patients should stop taking willow bark two weeks before having surgery to reduce the risk of poor wound healing and excessive bleeding.

  • Do Not Take If

  • You are taking warfarin or other blood thinners (In theory, based on the known effects of aspirin, willow bark may increase the risk of bleeding).
  • You are taking non-steroidal anti-inflammatory drugs (NSAIDs) (In theory, based on the known effects of aspirin, willow bark may increase the risk of stomach and intestinal damage and bleeding).

  • Side Effects

  • Rarely, nausea, vomiting, and gastrointestinal bleeding have been reported
  • Tinnitus (rare)
  • Kidney damage (rare)

  • Scientific Name

    Salix alba


    Common Name

    Bay willow, black willow, white willow

    Clinical Summary

    Derived from the bark of the tree. Willow bark contains salicin, the phytotherapeutic precursor of aspirin (acetylsalicylic acid). Products should be standardized to the content of salicin with daily doses ranging from 60-120 mg per day. Caution should be exercised in patients with known allergy or intolerance to aspirin or non-steroidal antiinflammatory drugs (NSAIDs). Willow bark should not be administered to children with a fever due to the risk of Reye's syndrome. Adverse reactions are analogous to those seen with aspirin, including gastrointestinal bleeding, nausea, and vomiting. May have additive effect with aspirin and NSAIDs and should therefore not be administered concurrently. Clinical studies demonstrate efficacy of willow bark in the management of back pain and osteoarthritis (7) (8). A systematic review of clinical trials suggests that it may also be effective in treating low back pain (1).


    Purported uses

  • Fever
  • Headaches
  • Inflammation
  • Influenza
  • Muscle pain
  • Pain
  • Weight loss

  • Constituents

  • Glycosides: Salicin, salicortin, picein, fragilin, tremulacin and triandrin
  • Esters of salicylic acid
  • Tannins
  • Catechins
  • Flavonoids
    (6)

  • Mechanism of Action

    All the phenolic glycosides of willow bark have similar physiological and pharmacological effects. In the intestinal tract and the liver, the phenolic glycosides convert to the active principle salicylic acid. Because of the time required for this conversion, the therapeutic properties of willow bark are expressed more slowly but continue to be effective for a longer time than if salicylate itself were administered. The tannins have astringent properties, and in vitro tests show that salicin and salicortin inhibit cyclooxygenase and an irreversible inhibition of thrombocytes is unlikely. Therefore, no increased interaction with anticoagulants should occur.
    (2) (3)

    Pharmacokinetics

    In a pharmacokinetic study in humans, three tablets containing willow bark (standardized to a total dose of 55 mg salicin) were administered to 12 male volunteers in three doses over a period of eight hours. The calculated half-life of salicin in the plasma was approximately 2.5 hours.
    (5)

    Adverse Reactions

    Infrequent: Nausea, vomiting, GI bleeding, tinnitus, and renal damage
    (4)

    Herb-Drug Interactions

    No interactions have been reported. However, due to the variable salicylate content found in willow back there are theoretical interactions.
    Anticoagulants / Antiplatelets: Theoretically, willow bark may increase the risk of bleeding.
    NSAIDs: Theoretically, willow bark may increase the risk of bleeding and GI mucosal damage.

    Lab Interactions

    Due to the unknown salicylate factor, use caution in interpreting test results that are sensitive to salicylates.

    Literature Summary and Critique

    Few controlled studies have been performed in humans; however, the pharmacological actions of salicylates are well published and applicable to willow bark.

    Chrubasik S, et al. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med 2000;109:9-14.
    Two hundred and ten patients were randomly assigned to receive an oral willow bark extract with either 120 mg or 240 mg of salicin or placebo, with tramadol as the sole rescue medication in a 4-week blinded trial. Principal outcome measured was proportion of patients who were pain-free without tramadol for at least 5 days during the final week of the study. One hundred and ninety one patients completed the study; the number of pain-free patients in the last week of treatment was 27 (39%) of 65 in the group receiving 240 mg salicin, 15 (21%) of 67 in the group receiving 120 mg salicin and 4 (6.8%) of 59 in the placebo group. Significantly, more patients in the placebo group required tramadol during each week of the study.

    Schmid B, et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized, placebo-controlled, double blind clinical trial. Phytother Res 2001;15:344-50.
    Seventy-eight patients were evaluated in this prospective study. Willow bark standardized to 60 mg salicin or placebo was administered as two tablets twice daily for 14 days. A significant decrease in joint pain was reported in the willow bark treatment group as compared to placebo. No significant change in stiffness or physical function was found. Adverse events were comparable between treatment groups. Willow bark was effective in reducing pain associated with osteoarthritis of the knee or hip.

    References

    1. Gagnier JJ, van Tulder MW, Berman B, et al. Herbal medicine for low back pain. Spine 2007;32(1):82-92.
    2. Tyler V. Herbs of Choice: The Therapeutic Use of Phytomedicinals. Binghamton: Pharmaceutical Press; 1994.
    3. Wichtl MW. Herbal Drugs and Phytopharmaceuticals. Boca Raton: Medpharm Scientific Publ; 1994.
    4. Schulz, et al. Rational Phytotherapy: A Physicians Guide to Herbal Medicines, 3rd ed. Berlin (Germany): Springer; 1996.
    5. Blumenthal, et al. Herbal Medicine Expanded Commission E Monographs, 1st ed. Austin: American Botanical Council; 2000.
    6. Newall CA, et al. Herbal Medicines: Guide for Health-Care Professionals, 1st ed. London: Pharmaceutical Press; 1998.
    7. Chrubasik S, et al. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med 2000;109:9-14.
    8. Schmid B, et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized, placebo-controlled, double blind clinical trial. Phytother Res 2001;15:344-50.

    Last Updated: Apr. 7, 2009
    E-mail your questions and comments to aboutherbs@mskcc.org.
    Bookmark and SharePrintEmail This Page